Molecular subtype shift in breast cancer upon trastuzumab treatment: A case report

Polish Journal of Pathology

Volumn 62, Issue 1, 2011, Pages 65-68

  Abolinš, Arnis ^a,b   Vanags, Andrejs ^a,b   Trofimovičs, Genadijs ^a,b   Miklaševics, Edvins ^a,b   Ardovskis, Janis G ^a,b   štrumfa, Ilze ^a,b  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

Author keywords

Breast cancer; Immunohistochemistry; Molecular subtype

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HER2 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ARTICLE; BREAST TUMOR; CASE REPORT; FATALITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 79957961324     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481-488.
2. Esteva FJ, Hortobagyi GN. Prognostic molecular markers in early breast cancer. Breast Cancer Res 2004; 6: 109-118.
3. Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 2009; 7: 4-13
4. Gardovskis A, Irmejs A, Miklasevics E, et al. Clinical, molecular and geographical features of hereditary breast/ovarian cancer in Latvia. Hereditary Cancer in Clinical Practice 2005; 3: 71-76.
5. Guarneri V, Conte P. Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy. Oncologist 2009; 14: 645-656.
6. Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: a critical review. J Clin Oncol 2008; 26: 2568-2581.
7. Irvin WJ Jr, Carey LA. What is triple-negative breast cancer? Eur J Cancer 2008; 44: 2799-2805.
8. Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007; 13: 4429-4439.